GIPMET MV 2

About this Product

Glimepiride, Metformin Hydrochloride, and Voglibose is a combination anti-diabetic medication used for the management of Type 2 Diabetes Mellitus. It helps control blood sugar levels through three complementary mechanisms: Glimepiride stimulates insulin secretion, Metformin reduces glucose production in the liver and improves insulin sensitivity, while Voglibose delays carbohydrate absorption from the intestine. This combination supports effective glycemic control, particularly in patients whose blood sugar levels are not adequately managed with single-drug therapy.